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Abstract 
Glycosaminoglycans, such as hyaluronic acid and chondroitin sulphate, are not only more and more required as main 
ingredients in cosmeceutical and nutraceutical preparations, but also as active principles in medical devices and 
pharmaceutical products. However, while biotechnological production of hyaluronic acid is industrially established 
through fermentation of Streptococcus spp. and recently Bacillus subtilis, biotechnological chondroitin is not yet on 
the market. A non-hemolytic and hyaluronidase negative S. equi subsp. zooepidemicus mutant strain was engineered 
in this work by the addition of two E. coli K4 genes, namely kfoA and kfoC, involved in the biosynthesis of chondroitin-
like polysaccharide. Chondroitin is the precursor of chondroitin sulphate, a nutraceutical present on the market as 
anti-arthritic drug, that is lately being studied for its intrinsic bioactivity. In small scale bioreactor batch experiments 
the production of about 1.46 ± 0.38 g/L hyaluronic acid and 300 ± 28 mg/L of chondroitin with an average molecular 
weight of 1750 and 25 kDa, respectively, was demonstrated, providing an approach to the concurrent production of 
both biopolymers in a single fermentation.
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Introduction
Hyaluronic acid (HA) and chondroitin sulphate (CS) are 
important glycosaminoglycans (GAG) found in the extra-
cellular matrix of vertebrates, and, although their appli-
cations in the biomedical field are quite diverse, growing 
interest towards both these compounds has indeed been 
observed in the last decade (Liu et  al. 2011; De Angelis 
2012). Due to its multiple properties including a high 
biocompatibility and lack of immunogenicity, HA is a 
heavily researched molecule with applications in cosmet-
ics and viscosurgery, healing and regeneration of wounds 
and lately investigated as a drug delivery agent (Maytin 
2016; Tripodo et  al. 2015; Moscovici 2015). CS on the 
other hand, is a nutraceutical marketed as anti-arthritic 
drug, and also an active pharmaceutical ingredient (API) 
in oral formulations for osteoarthritis (Henrotin et  al. 
2010); studies towards other interesting applications such 
as the production of biomaterials for tissue engineering 
are also under development (Christiani et al. 2016; Bish-
noi et  al. 2016). Moreover the combination of both HA 
and CS was shown to be effective for the treatment of 
urinary infections (Lazzeri et al. 2016; Ciani et al. 2016; 
Cervigni et al. 2016), cartilage repair (Henson et al. 2012), 
and early symptomatic knee osteoarthritis (Galluccio 
et al. 2015).
HA was the first GAG produced by fermentation, and 
more than 90% of HA present on the market is obtained 
from group C Streptococcus zooepidemicus, as well as 
Open Access
*Correspondence:  donatella.cimini@unicampania.it; chiara.schiraldi@
unicampania.it 
1 Department of Experimental Medicine, University of Campania 
Luigi Vanvitelli (ex Second University of Naples), via de Crecchio 7, 
80138 Naples, Italy
Full list of author information is available at the end of the article
Page 2 of 11Cimini et al. AMB Expr  (2017) 7:61 
more recently from Bacillus subtilis (de Olivera et  al. 
2016). K4 and K5 polysaccharides are consolidated pre-
cursors of chondroitin and heparin; however, CS is still 
obtained from limited and potentially harmful, animal 
sources such as chicken keel, shark fins, and swine or 
bovine trachea. Several efforts have been made to use 
E. coli K4, or its biosynthetic machinery in a different 
background, to generate cell factories for the production 
of chondroitin, and encouraging results were obtained 
(Cimini et al. 2013, 2015; He et al. 2015; Jin et al. 2016). 
The reason lies in the fact that the capsular polysaccha-
ride of this uropathogenic strain, composed of alternating 
residues of N-acetylgalactosamine (GalNAc) and glu-
curonic acid (GlcA), has a structure that closely resem-
bles the backbone of CS. Differences regard the presence 
of a fructose side branch on the GlcA residues and the 
absence of sulphate groups. Biotechnological chondroi-
tin (BC), produced from recombinant E. coli K4 (Cimini 
et al. 2013), was evaluated in comparison with CS show-
ing a higher reduction of the inflammatory response in 
IL-1b treated chondrocytes and the enhancement of their 
proliferation and phenotype preservation (Stellavato 
et al. 2016). Furthermore, the chemical conversion of bio-
technological chondroitin into CS by fructose branches 
cleavage and selective sulphation was recently accom-
plished (Bedini et al. 2011).
However, the gram− E. coli K4 releases in the medium 
also lipopolysaccharides that are the main product con-
taminants and need to be removed during the purifica-
tion strategy. For this reason we focused on the use of a 
gram+ strain belonging to a genus that is widely used for 
the production of hyaluronan (Liu et al. 2011).
The gene cluster responsible for the biosynthesis of 
the K4 polysaccharide is composed of three regions, 
two of which (1 and 3) are conserved among group II E. 
coli strains and dedicated to the transport and secretion 
of the CPS. The central region, region 2, includes genes 
involved in the synthesis of the serotype specific poly-
saccharide, and in polymer assembly and fructosylation. 
Among the known gene functions kfoC codes for chon-
droitin polymerase (Ninomiya et al. 2002), a bifunctional 
enzyme that transfers nucleotide sugars to the growing 
end of the polysaccharide, and kfoA codes for an epime-
rase that converts N-acetylglucosamine (GlcNAc) into 
GalNAc. In the present work the E. coli K4 genes, kfoC 
and kfoA, were expressed in a previously obtained non 
hemolytic, hyaluronidase negative S. equi subsp. zooepi-
demicus BA06 host (Schiraldi et  al. 2010) to implement 
its UDP-biosynthesis pathway and polymer assembly 
machinery for the production of chondroitin, thereby 
generating a cell factory for the obtainment of both 
biopolymers in a single fermentation event.
Materials and methods
Bacterial strains
Lactococcus lactis NZ900 was used as an intermediate 
host for plasmid construction. The mutant strain (hya-
luronidase-free and haemolytic negative) S. equi subsp. 
zooepidemicus BA06 strain was obtained as previously 
described (Schiraldi et  al. 2010). Plasmid pNZ8148 was 
obtained from Nizo (Netherlands).
Materials
Genomic DNA and plasmid DNA were isolated using 
Qiagen DNeasy kit, Qiagen miniprep kit, (Qiagen, Valen-
cia, CA) respectively according to the manufacturer’s 
instructions. Restriction endonuclease digestions, DNA 
ligations, agarose gel electrophoresis were performed 
using standard techniques (Sambrook and Russel 2001).
Construction of the kfoA and kfoC overexpressing strains
The kfoA and kfoC genes were amplified from E. coli K4 
genomic DNA. kfoA was amplified with primers kfoA_Up: 
5′- GGACGGTGCCATGGATGAATATATTAGTTACAG 
GTGGAG-3′containing the NcoI recognition site, and 
KfoA_Dw 5′-TCTCTAGACGCGGATCCTTAAATATAA 
CCATTTGGGTTTTTCA-3′ containing the BamHI and 
XbaI restriction sites. kfoC was amplified with primers 
kfoC_ Up 5′-CGGGATCCAGTGAGGAGTTACTGATGA 
GTATTCTTAATCAAG-3′ and kfoC_Dw 5′-GAGCTCTT 
ATAAATCATTCTCTATTTTTTCC-3′, containing the 
BamHI and SacI restriction sites respectively. Polymer-
ase chain reaction (PCR) was carried out with Expand 
High fidelity PCR System (Roche, Monza. Italy) accord-
ing to the manufacturer’s protocol. DNA fragments were 
recovered from agarose gels using the Qiaquick gel extrac-
tion kit (Qiagen, Valencia, CA). The kfoA and kfoC genes 
were sequentially cloned into plasmid pNZ8148 using L. 
lactis as intermediate host to improve transformation effi-
ciency (Additional file 1).
Efficiency of sub-cloning was verified by performing 
double digestions with BamHI and SacI on the recombi-
nant plasmid extracted from colonies of L. lactis grow-
ing on selective medium. Restriction endonucleases were 
purchased from New England Biolabs and ligases were 
purchased from Invitrogen (Carlsband, CA). Nucleotide 
sequencing of all PCR fragments cloned was carried out 
at BMR Genomics (Padova, Italy) to check whether any 
mutation was introduced.
pNZ8148kfoAkfoC was isolated from L. lactis-pNZ-
8148kfoAkfoC and electroporated into S. equi subsp. 
zooepidemicus BA06 slightly changing the protocol 
described by Marcellin et  al. (2010). Briefly, cells were 
grown on THY supplemented with 2  M glycine. About 
250  mL of fresh medium were inoculated with an o/n 
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pre-culture and grown for 3  h at 37  °C until OD530 
reached a value of about 0.6. Prior to harvesting, 0.2 mg/
mL of hyaluronidase (H3506, Sigma-Aldrich) were added 
to the broth and incubated for 30 min at the same tem-
perature. After centrifugation the pellet was resuspended 
in 0.5 M sucrose and washed twice; finally it was resus-
pended in about 600 μL of the same solution. The recom-
binant plasmid pNZ8148kfoAkfoC was added to the ice 
cold cell aliquot and electroporation was carried out on 
a Biorad Bio-Rad Gene Pulser (2  mm cuvettes, 2.0  kV, 
200 Ω, 25 μF) according to the protocol suggested by the 
manufacturer. Selection was performed on THY supple-
mented with 5  μg/mL of chloramphenicol. Plates were 
incubated o/n at 37 °C.
Shake flask experiments
All cultivations were conducted in 3  L flasks filled with 
0.6 L of medium in order to keep a 5:1 air–liquid ratio. 
Growth temperature was set at 37 °C and the culture was 
agitated at 140 rpm, in a rotary shaker incubator (model 
Minitron, Infors, Bottmingen, Switzerland). Experiments 
were performed on the medium containing per L: sucrose 
17 ± 1 g, yeast extract 10 g, KH2PO4 2 g, K2HPO4 9.7 g/L, 
MnSO4·4H2O 0.1  g, and 1  mL of microelement solu-
tion (CaCl2 2 g/L, MnSO4·4H2O 0.05 g/L, CuSO4·5H2O 
0.019 g/L, ZnCl2 0.046 g/L). pH was adjusted to 7.2 before 
strain inoculation. The medium also contained 5 μg/mL 
of chloramphenicol to avoid plasmid loss. Twenty ng/mL 
of nisin were added about 2–3 h after inoculating the cul-
ture to induce expression of recombinant proteins.
Experiments with the addition of 0.5  mM GalNAc, 
or 2  mM phosphatidylcholine after induction were also 
performed.
Determination of sucrose and acids produced during 
growth was performed by HPLC (UHPLC Dionex Ulti-
mate 3000; Thermofisher) on a Alltech IOA-2000 column 
(250  mm  ×  6.5  mm ID). Three mL of broth collected 
at T0 and at the end of the process were centrifuged 
and supernatants were ultrafiltered on 3  kDa centricon 
devices (Millipore, Bedford, MA, USA) at 5000×g and 
the flow through was used for analyses. Runs were per-
formed at 40 °C with 0.1% v/v sulphuric acid in water as 
mobile phase at a flow rate of 0.6 mL/min. Detection was 
performed via UV absorbance at 200 nm and refraction 
index (Shodex RI-101 detector, Max auto step 5.1 s, tem-
perature 32 °C, rise time 1 s, polarity plus, record range 
512 µRIU, integrator range 500 µRIU/UV).
Extraction of intracellular polysaccharides
In order to extract intracellular chondroitin and HA, 
about 10  g of wet cells were resuspended in 20  mL of 
distilled water and autoclaved at 120  °C for 15  min. 
After centrifugation the supernatant was recovered 
and precipitated on ice with 4 volumes of cold ethanol 
96% v/v, and stored at 4  °C o/n. The pellet, recovered 
after centrifugation was treated with 1  mg/mL DNase 
I (Applichem) in a buffer containing 100  mM Tris pH 
7.5, 50  mM MgCl2 and 10  mM CaCl2 for 1  h at 37  °C 
and successively digested with 2.5  mg/mL of Protease 
K from Aspergillus (Sigma-Aldrich) for 2 h at 56  °C. A 
second precipitation was repeated on the sample o/n 
at 4  °C and the resulting pellet was dried and used for: 
(a) hydrodynamic characterization (b) quantification of 
uronic acids through carbazole assay (Bitter and Muir 
1962) (c) determination of relative ratios of HA and 
chondroitin through high performance anion exchange 
chromatography with pulsed amperometric detection 
(HPAE-PAD) monosaccharide determinations after 
hydrolysis.
The powder obtained from the control sample was fur-
ther purified to verify the production of chondroitin in S. 
equi subsp. zooepidemicus-pNZ8148kfoAkfoC, through 
structure determination by NMR analysis.
Purification of intracellular chondroitin from S. equi subsp. 
zooepidemicus‑pNZ8148kfoAkfoC by fast protein liquid 
chromatography (FPLC)
About 100  mg of powder were dissolved in 5  mL of 
buffer A (20  mM sodium acetate, 0.5  M sodium chlo-
ride, pH 7.4) and loaded on an anion exchange column 
(HiPrep Q Sepharose 16/10 HP, 1.6  ×  10.0  cm, GE 
Healthcare, Milan, Italy), previously equilibrated with 
the same buffer, using an ÄKTA Explorer 100 purifier 
system (GE Healthcare, Milan, Italy), connected to the 
software UNICORN (GE Healthcare, Milan, Italy). The 
samples were eluted by applying a three steps gradient 
at 5, 10.5 and 100% of buffer B (20 mM sodium acetate, 
3  M sodium chloride, pH 7.4) in 3 column volumes, 
at a flow rate of 3 mL/min and collected in 2 mL frac-
tions. The chromatographic profiles were registered 
detecting the signal at 215 nm. The fractions containing 
a single peak were pooled together and each pool was 
loaded on a desalting column (HiPrep 26/10 Desalting, 
2.6 × 10.0 cm, GE Healthcare, Milan, Italy) previously 
equilibrated with pure water. Elution was performed 
by using the same ÄKTA purifier system, at flow rate 
of 1  mL/min, in 1.5 column volumes; the chromato-
graphic profiles were detected at 215  nm, the eluted 
peaks were collected and then freeze-dried (Christ 
Epsilon 2-6D, Martin Christ, Germany). After lyophili-
sation the peak fractions were analyzed by Size exclu-
sion chromatography-triple detector array (SEC-TDA), 
NMR and hydrolysed for HPAE-PAD sugar nucleotide 
determinations.
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Precipitation of extracellular HA and chondroitin
After growth in shakeflask the broth was centrifuged at 
6000×g, 4  °C for 30  min. The supernatant was precipi-
tated with 1.8 volumes of cold ethanol (99.9% v/v) o/n 
at 4 °C to remove HA. The precipitate was recovered by 
centrifugation and vacuum dried at 40  °C for 18  h. The 
supernatant underwent a second precipitation, to recover 
chondroitin, with ethanol up to 4 volumes at 4  °C o/n 
and the recovered precipitate was dried at 40  °C under 
vacuum.
Fermentation experiments
Fermentation experiments were carried out on a Biostat 
C plus reactor (Sartorius Stedim; Melsungen, Germany), 
with 1.6  L working volume. Agitation was provided by 
1 rushton impeller and 2 paddle impellers, suitable for 
viscous liquid mixing. Fermentation medium contained 
per L: sucrose 70 g, MgSO4·7H2O 2 g, yeast extract 20 g, 
Na2HPO4·12H2O 2.23  g, K2SO4 1.3  g, arginin 0.05  g 
and 2.5  mL of microelement solution. The preculture 
was performed in 1  L shakeflasks filled with 100  mL of 
medium, reported in the previous section, and grown on 
a rotary shaker at 200 rpm and 37 °C for 12–14 h. When 
pH dropped to 5 the flask culture was aseptically used 
to inoculate the fermenter: inoculum size was 5% of the 
volume of fermentation medium. A constant pH was 
maintained at 7.2 by automated addition of 6 M NaOH 
and 30% v/v sulfuric acid. Stirring and airflow rate were 
set at 200  rpm and 1.2/1.4 vvm for the duration of the 
experiment. The medium also contained 5  μg/mL of 
chloramphenicol and addition of 20 ng/mL of nisin was 
performed about 3 h after fermentation start. A pulse of 
sucrose re-establishing a concentration of 20  g/L in the 
broth was performed after 10 h of growth. At least four 
samples were withdrawn during the initial batch phase 
and at the end of the experiments to measure substrate 
consumption and production of lactic acid by HPLC as 
described in “Shakeflask experiments” section. The over-
all process lasted 18 h.
Fermentation broth downstream processing to obtain 
heteropolysaccharides (HA and chondroitin)
The recovered fermentation broth was added with 5% v/v 
of trichloroacetic acid (from a 50% w/v solution) before 
centrifugation at 6000×g for 60  min. The pH of the 
clarified supernatant was adjusted to 6.5 ± 0.2 with 6 M 
NaOH. A first ultrafiltration (UF) step was performed on 
a tangential flow filtration system (Sartoflow Alpha cross-
flow system, Sartorius) by using a polyethersulfone mem-
brane (0.1 m2) with a cut-off of 100 kDa. The supernatant 
was concentrated about eightfold, diafiltered with 2 vol-
umes of bidistilled water and the retentate was collected. 
The cassette was washed with 100 mL of water and the 
recovered solution was added to the concentrated super-
natant and precipitated with 1.8 volumes of cold ethanol 
(4 °C) o/n. The precipitate was vacuum dried at 40 °C for 
18 h.
The 100  kDa permeate was further concentrated on 
UF polyethersulfone membrane (0.1 m2) with a cut-off of 
10 kDa, concentrated tenfold and diafiltered with 300 mL 
of bidistilled water. The cassette was washed with 100 mL 
of purified water. Conductivity of the 10  kDa retentate 
and wash fraction was adjusted to about 15 mS/cm with 
NaCl before precipitation with 4 volumes of cold ethanol 
(4  °C) o/n. The recovered precipitate was vacuum dried 
at 40  °C for 18  h. The dried powder obtained from the 
100 and 10 kDa retentate samples were analysed by SEC-
TDA, HPAE-PAD and carbazole assay.
Intracellular polysaccharides were extracted as 
described in the previous paragraph (“Extraction of 
intracellular polysaccharides” section), and quantified as 
described above.
Molecular weight determination
The molecular mass determinations of HA and chondroi-
tin were carried out using the SEC-TDA 305 equipment 
by Viscotek (Malvern Instruments, Italy). Dried samples 
obtained after fermentation downstream treatments 
were dissolved in water and analysed whereas samples 
obtained from shakeflask experiments were dissolved in 
water and diafiltered with 2 volumes of bidistilled water 
on 3  kDa centrifugal filter devices (YM-10 Centricon, 
Millipore, Bedford, MA, USA) at 5000×g to remove salts 
and low molecular weight contaminants. Analyses were 
performed at concentrations ranging from 0.1 to 0.4 g/L 
for HA, and from 0.5 to 4 g/L for chondroitin, to have a 
column load for each sample (injection volume ×  sam-
ple concentration ×  intrinsic viscosity) of approximately 
0.2 dL, and runs were performed at 40 °C with a running 
time of 50 min. The fragment molecular weight distribu-
tion, molecular size distribution, polydispersity, hydro-
dynamic radius, and intrinsic viscosity were determined 
as described by La Gatta et al. (2010) and Restaino et al. 
(2017).
HPAE‑PAD
The aminosugars were identified in extracellular and 
intracellular polysaccharide samples by using the high-
performance chromatographic system equipped with a 
pulsed amperometric detector (PAD, Thermo Fisher Sci-
entific, Italy) on an anion exchange column (Carbopac 
PA1, Thermo Fisher Scientific, Italy) as previously dem-
onstrated by Marcellin et al. (2009). About 7 mg of pow-
der (obtained after lyophilisation) were hydrolyzed in 
1 M HCl for 18 h at 100 °C and analysed as described by 
Restaino et al. (2017).
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NMR analysis
NMR spectra were recorded with a Bruker DRX-600 
(1H: 600  MHz, 13C: 150  MHz) instrument equipped 
with a cryo probe, in D2O (acetone as internal stand-
ard, 1H: (CH3)2CO at δ  =  2.22  ppm; 13C: (CH3)2CO 
at δ  =  31.5  ppm). The distorsionless enhancement by 
polarization transfer-heteronuclear single-quantum cor-
relation (DEPT-HSQC) experiments were measured in 
the 1H-detected mode by single quantum coherence with 
proton decoupling in the 13C domain, by using data sets 
of 2048 × 256 points and typically 32 increments.
Results
Construction of recombinant S. equi subsp. 
zooepidemicus‑pNZ8148kfoAkfoC
The pathways leading to HA production in Streptococ-
cus spp. and the implemented changes performed in this 
work to obtain concurrent biosynthesis of chondroitin 
are shown in Fig. 1. PCR products were obtained utilizing 
E. coli K4 chromosomal DNA as a template, and specific 
oligonucleotide primers as indicated in the “Materials 
and methods” section. Sub-cloning for the construction 
of the recombinant plasmid pNZ8148kfoAkfoC, was per-
formed in L. lactis. After electroporation recombinant 
cells were selected on medium containing chlorampheni-
col. Double digestions that yielded bands of the expected 
molecular weight, and gene sequence analyses con-
firmed the absence of mutations. S. equi subsp. zooepi-
demicus BA06 was transformed by electroporation with 
pNZ8148kfoAkfoC and positive clones were selected on 
chloramphenicol.
Production of chondroitin and HA in shake flask 
experiments
Growth of S. equi subsp. zooepidemicus-pNZ8148kfoAk-
foC was performed on medium containing sucrose and 
yeast extract as main C and N sources, and expression of 
recombinant genes was induced by the addition of nisin. 
The supernatant and the biomass were recovered and 
treated as reported in the “Materials and methods” sec-
tion to establish the ratio of polysaccharides produced 
based on HPAE-PAD analyses of monomeric compo-
nents (amino sugars and uronic acid); total polysaccha-
rides produced were evaluated by carbazole assay based 
on uronic acid determination and results were consist-
ent with those obtained by SEC-TDA. The recombinant 
strain demonstrated to consume about 9 g/L of sucrose 
within 18  h of growth, and to produce about 11  g/L of 
lactic acid. Strain performance was also evaluated in the 
presence of 0.5 mM GalNAc and 2 mM phosphatidylcho-
line. GalNAc administration did not alter biomass and 
lactic acid production, however sucrose consumption 
was 30% lower compared to control conditions, resulting 
in higher yields (Table  1, Additional file  2). Upon addi-
tion of phosphatidylcholine medium opalescence was 
observed; this did not allow absorbance determinations 
during strain cultivations. Lactic acid final concentration 
and sucrose consumption were not altered by the addi-
tion of this phospholipid.
As reported in Table  1 about 90  mg/L of chondroi-
tin in addition to 415  mg/L of HA were obtained from 
the recombinant strain after induction of kfoC and kfoA 
expression with nisin (control), demonstrating the proof 
of principle of the engineering strategy. Chondroitin 
concentration remained unchanged following medium 
supplementation with 0.5  mM GalNAc, whereas it 
was slightly lower in the presence of phosphatidylcho-
line. Also the concentration of HA was not significantly 
altered in all conditions. However, due to the lower 
concentration of sugar consumed with 0.5  mM Gal-
NAc in the medium, the yield of chondroitin and HA 
with respect to starting sucrose (YBC/Suc and YHA/Suc, 
respectively) were 80 and 54% higher compared to those 
obtained in control conditions (Table 1). The addition of 
a higher concentration of GalNAc (5 mM) improved HA 
production and decreased the amount of produced chon-
droitin (data not shown).
Extremely low fractions of HA (0.6–1%) on the total 
polysaccharide produced, were found inside S. equi 
Fig. 1 HA biosynthesis pathways in Streptococcus. The pathway 
was modified by the introduction of two foreign genes (indicated in 
red), kfoA coding for an epimerase and kfoC coding for chondroitin 
polymerase leading to the production of chondroitin in S. equi subsp. 
zooepidemicus
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subsp. zooepidemicus-pNZ8148kfoAkfoC recombinant 
cells. Inversely, intracellular chondroitin amounts ranged 
from 15 to 27% of the total produced polysaccharide.
Hydrodynamic characterization
The molecular weight (Mw) of the produced polysaccha-
rides (HA and chondroitin) was assessed by SEC-TDA 
chromatography and results are reported in Table 2. The 
supernatants recovered from S. equi subsp. zooepidemi-
cus-pNZ8148kfoAkfoC grown in shakeflasks, were ini-
tially precipitated with 1.8 volumes of ethanol in order 
to recover HA. As reported in Table  2A in all growth 
conditions this precipitate contained three peak distribu-
tions, the most abundant of which was that with higher 
molecular weight with values ranging from 51 to 59% (1st 
Peak, representativeness). Medium supplementation with 
2 mM phosphatidylcholine increased the average Mw of 
this population by 18% compared to that obtained in con-
trol conditions; moreover, the analysis of Mw distribu-
tions of the subpopulations within this peak indicated a 
10% larger subpopulation of molecules with a Mw above 
2000  kDa. This result is also confirmed by the higher 
intrinsic viscosity (IV) of the sample recovered from 
recombinant cells growing in the presence of the above 
mentioned phosphatidylcholine. The presence of the lat-
ter also changed Mw distributions within the 3rd peak, in 
fact the amount of polymers with Mw > 50 kDa and with 
10 kDa < Mw < 50 kDa were 34% lower and 36% higher in 
this condition, respectively (Table 2A).
The supernatant was further precipitated with 4 vol-
umes of ethanol to recover chondroitin and eventually 
residual low Mw HA. In all conditions two peaks with an 
average molecular weight of 27 and 19  kDa were found 
(Table 2B).
Chondroitin purification and determination of chemical 
structure
Purification of chondroitin from the biomass was per-
formed, after cell lysis and precipitation, by anion 
exchange chromatography. The three step gradient 
allowed the identification of four major fractions that 
subsequently underwent salt removal on a desalting col-
umn, hydrolysis, and HPAE-PAD for determination of 
monosaccharide components. The peak eluted at 5% v/v 
of buffer B showed the highest concentration of GalN 
and was further analysed by SEC-TDA and NMR.
SEC-TDA analysis of the above indicated fraction 
showed a single peak (96% of representativeness) with 
a Mw of 28.4 kDa, a polydispersity index of 1.24 and an 
intrinsic viscosity equal to 1.09 as shown in the figure 
(Fig.  2). The chemical structure of the purified fraction 
was confirmed to be that of chondroitin by comparison 
of 1H and 13C NMR chemical shift data obtained by a 
DEPT-HSQC experiment (Fig. 3) with those reported in 
literature (Mucci et al. 2000).
This confirmed the production of chondroitin poly-
saccharide upon expression of the two E. coli K4 genes 
namely kfoA, that converted UDP-GlcNAc into UDP-
GalNAc, and kfoC, coding for chondroitin polymerase, 
that is essential for polymer assembly, in S. equi subsp. 
zooepidemicus BA06.
Batch experiments on 3 L‑bioreactors
S. equi subsp. zooepidemicus-pNZ8148kfoAkfoC was 
grown in a 3  L reactor on semidefined medium and 
expression of the foreign genes, kfoC and kfoA, was 
induced during exponential phase by the addition of 
nisin. The process lasted 18 h with a final concentration 
of biomass of about 8.34 ± 0.92 OD600 and a production 
Table 1 S.  equi subsp. zooepidemicus-pNZ8148kfoAkfoC grown in shakeflasks on semidefined medium
Production of HA and chondroitin were analysed in the presence of inducer (nisin) alone or in combination with either GalNAc or phosphatidylcholine. Experiments 
lasted 18 h. Biomass and polymer concentrations indicated in the table were determined after 18 h of growth
nd not detectable
a Percentage of intracellular polymer on the total produced of each type (HA or chondroitin)










YHA/Suc (mg/g) YLA/Suc (g/g)
Nisin 20 ng/mL 8.2 ± 0.7 75 ± 8 13 ± 1
15%a
9.8 ± 0.3 412 ± 25 2.7 ± 0.2
0.6%a
47 ± 7 1.2 ± 0.1
Nisin 20 ng/
mL, 0.5 mM 
GalNAc
8.7 ± 0.7 68 ± 6 24 ± 2
26%a
17.7 ± 1.5 366 ± 31 4.1 ± 0.4
1.1%a
71 ± 10 2.1 ± 0.2
Nisin 20 ng/
mL, 2 mM 
phosphatidyl-
choline
nd 44 ± 4 16 ± 2
27%a
5.8 ± 0.85 428 ± 38 2.7 ± 0.3
0.6%a
42 ± 6 1.2 ± 0.1
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of 50 ± 8 g/L of lactic acid (Table 3). The C source was 
not completely consumed, in fact, a residue of about 
21 ±  2  g/L of sucrose was found in the medium at the 
end of the process (Additional file  3). The fermentation 
broth was treated with TCA to lower viscosity and to pre-
cipitate proteins in the medium and after centrifugation 
it was ultrafiltered/diafiltered on 100 kDa membranes to 
recover the high molecular weight fraction of exopolysac-
charides; the permeate was concentrated and diafiltered 
on 10  kDa membranes. Both retentates were precipi-
tated with ethanol in different proportion to recover HA 
and chondroitin enriched fractions, respectively (Addi-
tional file 4). An average production of 1.44 ± 0.36 and 
0.22 ± 0.01 g/L of secreted HA and chondroitin, respec-
tively, were found in the broth at the end of the process 
(Table 3; Additional file 3). Mw and polydispersity of the 
two produced polymers is reported in Fig. 4. The polysac-
charide fraction extracted from the biomass after 18 h of 
growth consisted of about 0.021 and 0.082 g/L of HA and 
BC; data were normalized on the volume of recovered 
broth and on the concentration of wet biomass obtained 
at harvesting (Additional file 3). 
Table 2 SEC-TDA analyses of polysaccharides produced by the recombinant strain of S. equi subsp. zooepidemicus-pNZ-
8148kfoAkfoC during growth in shakeflasks on semidefined medium
Mw/Mn polymer polydispersity, IV intrinsic viscosity
a Molecular weight distribution of subpopulations found in the 1st peak indicating the percentage of molecules with a Mw > 2000 kDa
b Molecular weight distribution of subpopulations found in the 3rd peak
S. equi subsp. zooepidemicus‑pNZ‑
8148kfoAkfoC
S. equi subsp. zooepidemicus‑pNZ‑
8148kfoAkfoC + 0.5 mM GalNAc
S. equi subsp. zooepidemicus‑pNZ‑
8148kfoAkfoC + 2 mM phosphati‑
dylcholine
A: Analyses of polysaccharides precipitated with 1.8 volumes of ethanol
Ethanol precipitation (V) 1.8 1.8 1.8
 1st peak
  Mw (kDa) 1710 Mw distributiona: 
31.7% > 2000 kDa
1709 Mw distributiona: 
32.1% > 2000 kDa
1983 Mw distributiona: 
42.5% > 2000 kDa
  Mw/Mn 1.38 1.41 1.31
  IV (dL/g) 24.5 24.4 27.0
  Representativeness (%) 51.3 55.6 58.6
 2nd peak
  Mw (KDa) 720 241 511
  Mw/Mn 1.67 1.05 1.02
  IV (dL/g) 4.6 4.8 8.3
  Representativeness (%) 5.1 5.4 3.2
 3rd peak
  Mw (kDa) 53 Mw distributionb: 
10 kDa < 48.7% < 50 kDa
51.3% > 50 kDa
41.8 Mw distributionb: 
10 kDa < 48.3% < 50 kDa
51.7% > 50 kDa
70 Mw distributionb: 
10 kDa < 66.0% < 50 kDa
34.0% > 50 kDa
  Mw/Mn 1.55 1.24 1.22
  IV (dL/g) 1.0 1.0 1.0
  Representativeness (%) 28.9 24.9 21.3
B: Analyses of polysaccharides precipitated with 4 volumes of ethanol
Ethanol precipitation (V) 4 4 4
 1st peak
  Mw (KDa) 27.9 27.5 27.6
  Mw/Mn 1.07 1.06 1.05
  IV (dL/g) 0.1 0.2 0.1
  Representativeness (%) 22.4 24.3 14.8
 2nd peak
  Mw 19.8 19.2 19.3
  Mw/Mn 1.02 1.01 1.02
  IV (dL/g) 0.1 0.1 0.1
  Representativeness (%) 77.5 75.5 85.1
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Discussion
In the present work we reported the construction of a 
S. equi subsp. zooepidemicus recombinant strain that 
expresses two E. coli K4 genes, namely kfoC and kfoA, 
involved in the biosynthesis of chondroitin-like capsular 
polysaccharide. The aim of the study was to use a non-
hemolytic and hyaluronidase negative microorganism, 
that already represents a consolidated industrial host for 
the production of HA, and endow it with the ability to 
additionally produce chondroitin, generating a cell fac-
tory for both biopolymers.
The difference between disaccharide units composing 
HA and chondroitin lies in the presence of either Glc-
NAc or GalNAc, respectively, bound to GlcA residues. 
Expression of kfoA encoding an epimerase that converts 
UDP-GlcNAc into UDP-GalNAc was not sufficient to 
redirect the pathways dedicated to HA biosynthesis in 
S. equi subsp. zooepidemicus to the production of chon-
droitin as well, probably due to the absence of a spe-
cific polymerase needed to bind nucleotide sugars and 
allow polymer assembly (data not shown). Concurrent 
expression of the kfoC encoded chondroitin polymerase, 
was necessary to produce chondroitin as confirmed by 
Fig. 2 SEC-TDA chromatogram of intracellular chondroitin purified 
by ethanol precipitation, anion exchange and desalting chromatog-
raphies from S. equi subsp. zooepidemicus-pNZ8148kfoAkfoC. RI signal 
(red), viscometer signal (blue), right angle light scattering (green) and 
low angle light scattering (black)
Fig. 3 1H and DEPT-HSQC NMR (600 MHz, 298 K, D2O, acetone as internal standard) spectra of chondroitin polysaccharide from S. equi subsp. 
zooepidemicus-pNZ8148kfoAkfoC [chemical structure and numbering of chondroitin is shown in the inset; in the parenthesis below signal attribu-
tions are indicated the 1H and 13C (in italic) chemical shift values]
Page 9 of 11Cimini et al. AMB Expr  (2017) 7:61 
HPAE-PAD and NMR analyses. The recombinant strain 
S. equi subsp. zooepidemicus-pNZ8148kfoAkfoC co-
produced about 400 and 90 mg/L of HA and chondroi-
tin, respectively, in shakeflasks on semidefined medium 
containing sucrose and yeast extract as main C and N 
sources. A productivity of 23 mg/Lh of HA was obtained 
considering the entire process duration. The final titer 
and productivity of chondroitin was lower with respect 
to HA, but comparable to that obtained by growing 
a natural producer such as E. coli K4 in shakeflasks on 
semidefined medium (Cimini et  al. 2010). While HA 
was completely secreted from recombinant cells with a 
residual intracellular concentration of about 1% of the 
total polysaccharide produced, a higher concentration 
of chondroitin, ranging between 15 and 27%, was found 
upon biomass extraction (Table  1), probably indicat-
ing a lower efficiency of the secretion system with the 
new polymer. Two aspects were further investigated in 
shakeflasks, namely (i) whether GalNAc supplementa-
tion could partially redirect fluxes towards chondroitin 
production (ii) whether addition of phosphatidylcholine 
would increase HA molecular weight.
The crystal structure of chondroitin polymerase 
suggested a higher binding affinity for UDP-GalNAc 
(Zanfardino et  al. 2010) and, a simulated implementa-
tion of the UDP-GalNAc productive branch by glutamine 
addition boosted capsular polysaccharide production in 
recombinant E. coli K4 (Cimini et al. 2015). However, in 
the present work addition of GalNAc only resulted in a 
slight reduction of HA titers, leaving the production of 
chondroitin unchanged and a higher (80%) concentration 
of the latter inside the cells compared to that found in 
control conditions. Addition of growing concentrations 
of GalNAc up to 5 mM did not improve results leading, 
on the contrary, to higher HA final titers thereby also 
decreasing the amount of chondroitin produced (data 
not shown).
One of the most pursued research goals about HA pro-
duction is to obtain HA with the highest possible molec-
ular weight and several critical cultivation parameters 
such as pH, temperature, aeration conditions etc. were 
investigated so far (Liu et  al. 2011). The ratio of UDP-
GlcA and UDP-GlcNAc influences the molecular weight 
of HA produced by Streptococcus strains (Badle et  al. 
2014), however genetic changes made in this work did 
not exert such effect.
Sun et al. (2012) interestingly found that the presence 
of phosphatidylcholine in the growth medium directed 
Table 3 S. equi subsp. zooepidemicus-pNZ8148kfoAkfoC grown in  3  L bioreactors in  batch conditions on  semidefined 
medium













8.34 ± 0.92 0.11 ± 0.01 0.62 ± 0.06 1.44 ± 0.36 0.22 ± 0.01 0.02 ± 0.00 0.08 ± 0.06
Fig. 4 Average Mw and Mw/Mn obtained for HA and BC produced during batch fermentations on 3 L bioreactors
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more carbon to HA synthesis (production raised by 17%) 
by enhancing ATP production. It also increased the pol-
ymer molecular weight by 67% in controlled bioreactor 
experiments. Addition of the same phospholipid here 
did not enhance HA production. Nevertheless, an 18% 
higher average molecular weight was observed, thereby 
obtaining HA with average Mw of 1.98  kDa. In fact, 
interestingly, SEC-TDA showed that within the highest 
molecular weight peak (1st peak) obtained after the first 
precipitation step with ethanol, a 10% larger subpopula-
tion of molecules with a Mw above 2000 kDa was found, 
compared to that observed in the absence of phosphati-
dylcholine (Table 2). Similar polydispersity (Mw/Mn) and 
higher IV compared to the control (27.0 vs 24.5  dL/g) 
further confirm data robustness. Moreover, the same 
sample showed, within the 3rd peak, a smaller amount of 
polymers with Mw > 50 kDa indicating a broader effect of 
phosphatidylcholine on the distribution of high and low 
molecular weight HA polymers.
SEC-TDA analyses of supernatants further precipitated 
with 4 volumes of ethanol indicated the presence of two 
peaks with an average molecular weight of 27 and 19 kDa. 
By comparing the relative abundance of the two peaks 
identified by SEC-TDA to results obtained by hydrolysis 
and HPAE-PAD, the two populations principally corre-
spond to chondroitin together with residual polysaccha-
rides from the medium and a lower HA contamination.
Constant air sparging and pH control led to the pro-
duction of about 1.46 and 0.3 g/L of HA and BC respec-
tively in 3  L bioreactors, in batch mode. Twenty-seven 
percent of chondroitin was retained inside the cells, 
whereas most HA was found in the extracellular envi-
ronment (1.5% inside on the total produced), confirm-
ing shakeflask results. The polymers produced after 18 h 
of growth were characterized after 1/2 ultrafiltration 
steps and precipitation with differential ethanol percent-
ages showing an average Mw of 1.75  ±  0.14  MDa and 
25 ± 3 kDa for HA and BC, respectively.
Engineering of S. equi subsp. zooepidemicus BA06, a 
hyaluronidase and haemolysin-free natural producer 
of HA, was accomplished in this work. The strain was 
enriched by recombinant inducible expression of two E. 
coli K4 genes, kfoA and kfoC, that are involved in the bio-
synthesis of chondroitin-like polysaccharide. As proved 
by HPAE-PAD and NMR the recombinant strain pro-
duced both polymers with an HA:BC ratio equal to 5:1, 
for extracellular species, and 1:4/5 for intracellular spe-
cies. To our knowledge this is the first study that pro-
vides an approach to the concurrent production of HA 
and chondroitin in a highly exploited industrial work-
horse, that differently from other potentially harmful 
Streptococcus strains is non-hemolytic and hyaluronidase 
negative. This gives the opportunity to obtain both 
polymers from a single bioprocess; since the HA secre-
tion apparatus is not as efficient for chondroitin release, 
biomass could be the source of a chondroitin rich poly-
saccharide fraction of low Mw (<40  kDa), whereas the 
supernatant the source of almost pure and high Mw HA.
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